J B Chemicals AND Pharmaceuticals Limited — Ciprofloxacin Exporter Profile
Indian Pharmaceutical Exporter · #9 for Ciprofloxacin · $5.3M export value · DGFT Verified
J B Chemicals AND Pharmaceuticals Limited is the #9 Indian exporter of Ciprofloxacin with $5.3M in export value and 196 verified shipments. J B Chemicals AND Pharmaceuticals Limited holds a 1.8% market share in Ciprofloxacin exports across 7 countries. The company exports 20 pharmaceutical products worth $47.9M across 12 therapeutic categories.
J B Chemicals AND Pharmaceuticals Limited — Ciprofloxacin Export Profile: Buyers & Destinations
Where Does J B Chemicals AND Pharmaceuticals Limited Export Ciprofloxacin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $2.7M | 121 | 61.0% |
| SOUTH AFRICA | $910.2K | 50 | 20.4% |
| PHILIPPINES | $322.4K | 12 | 7.2% |
| KENYA | $235.6K | 18 | 5.3% |
| ETHIOPIA | $184.4K | 20 | 4.1% |
| MALAYSIA | $82.5K | 9 | 1.8% |
| YEMEN, DEMOCRATIC | $9.2K | 1 | 0.2% |
J B Chemicals AND Pharmaceuticals Limited exports Ciprofloxacin to 7 countries. The largest destination is UNITED STATES accounting for 61.0% of J B Chemicals AND Pharmaceuticals Limited's Ciprofloxacin shipments, followed by SOUTH AFRICA (20.4%) and PHILIPPINES (7.2%). These destinations reflect J B Chemicals AND Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ciprofloxacin from J B Chemicals AND Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| RISING PHARMA HOLDINGS, INC | UNITED STATES | $1.0M | 54 |
| RISING PHARMA HOLDINGS INC | UNITED STATES | $839.4K | 42 |
| RISING PHARMA HOLDINGS, INC. | UNITED STATES | $752.4K | 21 |
| ARYA PHARMA (PTY) LTD. | SOUTH AFRICA | $363.6K | 12 |
| BIOTECH LABORATORIES (PTY) LTD | SOUTH AFRICA | $305.3K | 23 |
| RITEMED PHILS INC | PHILIPPINES | $161.5K | 6 |
| RITEMED PHILS.INC | PHILIPPINES | $134.2K | 5 |
| PLANET PHARMACEUTICALS U LTD | KENYA | $109.7K | 4 |
| RISING PHARMA HOLDINGS INC. | UNITED STATES | $98.6K | 4 |
| PLANET PHARMACEUTICALS (U) LTD. | KENYA | $95.1K | 13 |
J B Chemicals AND Pharmaceuticals Limited supplies Ciprofloxacin to 33 buyers globally. The largest buyer is RISING PHARMA HOLDINGS, INC (UNITED STATES), followed by RISING PHARMA HOLDINGS INC (UNITED STATES) and RISING PHARMA HOLDINGS, INC. (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ciprofloxacin Export Value and How Much Does J B Chemicals AND Pharmaceuticals Limited Contribute?
India exported $74.6M worth of Ciprofloxacin through 14,146 shipments from 1001 suppliers to 180 countries, serving 3,081 buyers globally. J B Chemicals AND Pharmaceuticals Limited contributes $5.3M to this total, accounting for 1.8% of India's Ciprofloxacin exports. J B Chemicals AND Pharmaceuticals Limited ships Ciprofloxacin to 7 countries through 33 buyers.
What Is the Average Shipment Value for J B Chemicals AND Pharmaceuticals Limited's Ciprofloxacin Exports?
J B Chemicals AND Pharmaceuticals Limited's average Ciprofloxacin shipment value is $27.1K per consignment, based on 196 shipments totaling $5.3M. The largest destination is UNITED STATES (61.0% of J B Chemicals AND Pharmaceuticals Limited's Ciprofloxacin exports).
How Does J B Chemicals AND Pharmaceuticals Limited Compare to Other Indian Ciprofloxacin Exporters?
J B Chemicals AND Pharmaceuticals Limited ranks #9 among 1001 Indian Ciprofloxacin exporters with a 1.8% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($20.4M), AUROBINDO PHARMA LTD ($11.4M), SENTISS PHARMA PRIVATE LIMITED ($8.8M). J B Chemicals AND Pharmaceuticals Limited processed 196 shipments to 7 destination countries.
What Ciprofloxacin Formulations Does J B Chemicals AND Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CIPROFLOXACIN TAB USP500MG 500PK USA EXP | $381.5K | 9 |
| CIPROFLOXACIN TABLET USP 500MG.EACH TABL | $353.6K | 8 |
| CIPROFLOXACIN TABLET USP 500MG.EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDEUSP 500MG.CIPROFLOXACIN TABNOS | $325.1K | 12 |
| CIPROFLOXACIN TABS 500 MG10 X 10 PHL EXP | $322.4K | 12 |
| CIPROFLOXACIN TABLET USP 500MG.EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDEUSP 500MG CIPROFLOXACIN TAB USP 500MG | $295.0K | 6 |
| BIOTECH CIPROFLOXACIN 500MG 10TAB SA EXP | $181.2K | 9 |
| CIPROGYL IV 100ML ETH EXP (NIPPLE HEAD)CIPROFLOXACIN | $156.0K | 18 |
| CIPROFLOXACIN TABLET USP 500MG EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDEUSP 500MG CIPROFLOXACIN TAB USP500MG | $150.0K | 3 |
| CIPROFLOXACIN TABLET USP 500MG EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDEUSP 500MG CIPROFLOXACIN TAB USP 500MGNOS | $126.7K | 6 |
| CIPROFLOXACIN TABLET USP 500MG.EACH TABLET CONTAINS CIPROFLOXACIN HYDROCHLORIDEUSP 500MG.CIPROFLOXACIN TAB USP500MG | $100.0K | 2 |
J B Chemicals AND Pharmaceuticals Limited exports 102 distinct Ciprofloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CIPROFLOXACIN TAB USP500MG 500PK USA EXP with 9 shipments worth $381.5K.
Regulatory Requirements: Exporting Ciprofloxacin to Key Markets
What J B Chemicals AND Pharmaceuticals Limited must comply with to export Ciprofloxacin to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does J B Chemicals AND Pharmaceuticals Limited Compare to Nearest Ciprofloxacin Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | AUROBINDO PHARMA LTD | $11.4M | 250 | 13 | $45.4K |
| 6 | SENTISS PHARMA PRIVATE LIMITED | $8.8M | 177 | 7 | $50.0K |
| 9 | J B CHEMICALS AND PHARMACEUTICALS LIMITED ★ | $5.3M | 196 | 7 | $27.1K |
| 11 | FDC LIMITED | $4.8M | 99 | 6 | $48.1K |
| 7 | MEDOPHARM | $4.5M | 91 | 19 | $50.0K |
J B Chemicals AND Pharmaceuticals Limited ranks #9 among 1001 Indian Ciprofloxacin exporters. Average shipment value of $27.1K compared to the market average of $74.5K. The closest competitors by value are AUROBINDO PHARMA LTD and SENTISS PHARMA PRIVATE LIMITED.
Which Indian Ports Ship Ciprofloxacin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,828 | 12.9% |
| SAHAR AIR | 1,481 | 10.5% |
| NHAVA SHEVA SEA (INNSA1) | 1,254 | 8.9% |
| DELHI AIR CARGO ACC (INDEL4) | 969 | 6.8% |
| JNPT/ NHAVA SHEVA SEA | 766 | 5.4% |
| DELHI AIR | 722 | 5.1% |
| JNPT | 595 | 4.2% |
| Bombay Air | 375 | 2.7% |
Geopolitical & Trade Policy Impact on J B Chemicals AND Pharmaceuticals Limited's Ciprofloxacin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like JB Pharma. The Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts the profitability of exports to Europe and the US East Coast, necessitating strategic adjustments in pricing and logistics.
Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture market share previously held by Chinese manufacturers. JB Pharma can leverage this shift by emphasizing its compliance with stringent US regulatory standards and its capacity to meet large-scale demands.
The recent India–European Union Free Trade Agreement, concluded in January 2026, eliminates tariffs on Indian pharmaceuticals entering the EU market. This development offers JB Pharma a competitive advantage, potentially increasing its export volumes to Europe and enhancing its market presence.
J B Chemicals AND Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. JB Pharma's adherence to FDA, WHO, and EU Good Manufacturing Practices (GMP) ensures the quality and safety of its products, facilitating access to regulated markets. The evolving regulatory environment, including the EU's Falsified Medicines Directive, requires continuous investment in serialization and traceability systems. JB Pharma's proactive approach to these requirements underscores its commitment to quality and patient safety.
About J B Chemicals AND Pharmaceuticals Limited
J B Chemicals AND Pharmaceuticals Limited exports 20 products worth $47.9M. Beyond Ciprofloxacin, top products include Cetirizine, Metronidazole, Enalapril, Caffeine, Vitamin. View the complete J B Chemicals AND Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ciprofloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ciprofloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: J B Chemicals AND Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 231 individual customs records matching J B Chemicals AND Pharmaceuticals Limited exporting Ciprofloxacin, covering 102 formulations to 7 countries via 33 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 180+ countries, 3,081+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ciprofloxacin Export Data from J B Chemicals AND Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for J B Chemicals AND Pharmaceuticals Limited's Ciprofloxacin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
J B Chemicals AND Pharmaceuticals Limited
Full Company Profile →
20 products · $47.9M total trade · 12 categories
Ciprofloxacin Stats
Company Overview
Top Products by J B Chemicals AND Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for J B Chemicals AND Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ciprofloxacin. For current shipment-level data, contact TransData Nexus.